Showing results (141-150 of 217) with videos related to

Sort By:
Pageof 22
Cancers|March 14, 2026
Tumor Mutational Burden as a Prognostic Biomarker in Follicular LymphomaMarta Lafuente, Ramón Diez-Feijóo, Marta García-Recio, et al.
Blood Advances|October 27, 2020
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic featuresXavier Calvo, Nieves Garcia-Gisbert, Ivonne Parraga, et al.
Experimental and Molecular Pathology|September 27, 2015
Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanomaLinea Melchior, Morten Grauslund, Beatriz Bellosillo, et al.
British Journal of Haematology|May 26, 2017
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemiaAlberto Alvarez-Larrán, Alicia Senín, Concepción Fernández-Rodríguez, et al.
Blood Advances|October 14, 2021
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivityConcepción Fernández-Rodríguez, Juan José Rodríguez-Sevilla, Lierni Fernández-Ibarrondo, et al.
European Journal of Haematology|May 8, 2015
Molecular diagnostics of myeloproliferative neoplasmsStephen E Langabeer, Hajnalka Andrikovics, Julia Asp, et al.
NPJ Breast Cancer|June 20, 2025
Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trialJoan Albanell, Angelo Gámez Pozo, Carlos L Arteaga, et al.
Cancers|August 26, 2023
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at DiagnosisSara Montesdeoca, Nieves García-Gisbert, Xavier Calvo, et al.
Frontiers in Oncology|February 28, 2022
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerAlberto Ocaña, Jose Ignacio Chacón, Lourdes Calvo, et al.
Pageof 22